Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Publication Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach CertaraSeptember 15, 2017
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal White Paper Drug Asset Evaluation: Increasing “Probability of Success” of a Deal Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…CertaraAugust 24, 2017
Investigational Drug Gap Analysis Brochure Investigational Drug Gap Analysis As the process of drug development has increased in cost and complexity, Certara has developed…CertaraAugust 14, 2017
Clinical Pharmacology—The Quarterback of Drug Development Press Coverage Clinical Pharmacology—The Quarterback of Drug Development Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…CertaraAugust 14, 2017
Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis Blog Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis Do you get anxious about taking tests? Many people do because they want to show…CertaraMay 25, 2017
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor CertaraJanuary 10, 2017
Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Publication Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs CertaraJune 1, 2016
Trial Designs—Non-inferiority vs. Superiority vs. Equivalence BlogKnowledge Base Trial Designs—Non-inferiority vs. Superiority vs. Equivalence The primary purpose of a clinical trial is to address a scientific hypothesis. To address…CertaraJanuary 1, 2011